Scientists develop new drugs for Parkinson's disease
Scientists develop new drugs for Parkinson's disease June 04, 2019 Source: Science Report Institutions such as Osaka University of Japan have recently developed new drugs that inhibit the accumulation of proteins associated with Parkinson's disease, and have been shown to improve the symptoms of Parkinson's disease in animal experiments. The production of Parkinson's disease is thought to be related to the abnormal accumulation of a protein called "α-synuclein" in the brain, and there is no fundamental treatment to date. Research groups at Osaka University and Tokyo Medical and Dental University have recently developed oligonucleotide drugs that inhibit the accumulation of "α-synuclein", which bind to and block the "α-synuclein" gene. Synthesize to inhibit the accumulation of this protein. In the experimental mouse experiment, the researchers found that the accumulation of "α-synuclein" in the Parkinson's disease model rats treated with the drug was inhibited, and the mobility disorder was also improved. The team said it expects the findings and methods to be an epoch-making treatment for Parkinson's disease and is expected to be applied to the treatment of other neurological diseases. Related research results were published on the 21st in the British Science Report. (Source: Xinhua News Agency, Huayi) Related paper information: https://doi.org/10.1038/s41598-019-43772-9 Jiangsu Tiera Biotechnology Co., Ltd , https://www.tierabio.com